Provided by Tiger Trade Technology Pte. Ltd.

Genelux Corporation

2.54
+0.02000.79%
Volume:231.94K
Turnover:609.64K
Market Cap:114.92M
PE:-2.95
High:2.73
Open:2.55
Low:2.50
Close:2.52
52wk High:8.54
52wk Low:2.29
Shares:45.25M
Float Shares:36.90M
Volume Ratio:1.72
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8623
EPS(LYR):-0.8647
ROE:-177.93%
ROA:-77.89%
PB:7.13
PE(LYR):-2.94

Loading ...

Genelux publishes case report from dose escalation portion of OLVI-VEC-202-SCLC

TIPRANKS
·
Yesterday

Genelux Reports 16.7-Month PFS in Phase 1b/2 Olvi-Vec Trial Case Study for Platinum-Relapsed SCLC

Reuters
·
Yesterday

Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy

GlobeNewswire
·
Yesterday

Genelux Publishes Corporate Presentation Highlighting Olvi-Vec Late-Stage Ovarian Cancer Program Focused on Platinum Sensitization

Reuters
·
Aug 14

Genelux Q2 EPS $(0.21) Misses $(0.19) Estimate

Benzinga Earnings
·
Aug 14

Genelux Posts Wider-than-Expected Q2 Loss on Higher R&D Expenses

Reuters
·
Aug 14

Press Release: Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates

Dow Jones
·
Aug 14

Genelux Q2 FY26 Net Loss Widens to $9.47 Million; Revenue Flat at no Revenue

Reuters
·
Aug 14

Genelux Corp Expected to Post a Loss of 20 Cents a Share - Earnings Preview

Reuters
·
Aug 01

Attovia Therapeutics Appoints John W. Smither to Board of Directors

THOMSON REUTERS
·
Jul 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 30

Genelux Reports Viro-15 Translational Analysis Supports Olvi-vec Immune Activation, Platinum Resensitization in Ovarian Cancer

Reuters
·
Jun 30

Genelux shareholders elect John Smither to board at annual meeting

Reuters
·
Jun 23

Genelux director Thomas John disposes of 10,000 common shares worth $29,801

Reuters
·
Jun 03

Genelux Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Genelux Q1 net loss widens, misses analyst expectations

Reuters
·
May 08

Genelux Q1 EPS $(0.20), Inline

Benzinga Earnings
·
May 08

Genelux Q1 2026 net loss widens to $8.9 million; no revenue

Reuters
·
May 08

Press Release: Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates

Dow Jones
·
May 08

Genelux Corp expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 02